Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|August 27, 2025
Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort studyPaul McGale, David Dodwell, Andrew Challenger, et al.
International Journal of Cancer|December 21, 2022
Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis ServiceAndrew Bacon, Kwok Wong, Malee S Fernando, et al.
JNCI Cancer Spectrum|August 11, 2023
Ki67 and breast cancer mortality in women with invasive breast cancerJake Probert, David Dodwell, John Broggio, et al.
British Journal of Cancer|January 6, 2026
Distant recurrence and margin involvement in invasive breast cancerSarah Michael, John Broggio, Sarah Bowers, et al.
BMJ (Clinical Research Ed.)|June 13, 2023
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort studyCarolyn Taylor, Paul McGale, Jake Probert, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
British Journal of Cancer|October 26, 2016
Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in EnglandHenrik Møller, Katherine Henson, Margreet Lüchtenborg, et al.
JAMA Dermatology|November 29, 2018
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in EnglandZoë C Venables, Philippe Autier, Tamar Nijsten, et al.
BMJ Open|January 12, 2024
Cohort profile: the National Congenital Anomaly Registration Dataset in EnglandJennifer M Broughan, Ben Wreyford, Danielle Martin, et al.
Blood Advances|March 4, 2026
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 yearsAndrew Challenger, Paul McGale, Jake Probert, et al.
Pageof 3